丙肝感染者中的乙肝检测、关怀衔接与疫苗接种覆盖率
该回顾性队列研究基于美国亚特兰大Grady健康系统2004至2016年4224例HCV感染者登记数据,描述乙肝检测率、HBsAg阳性者关怀衔接及疫苗接种情况。结果显示完全乙肝血清学检测、乙肝导向关怀和疫苗接种均存在不足,提示需加强这些环节。
要点
- 4224例HCV感染者中86%有HBsAg检测结果,1.2%为HBsAg阳性。
- 仅55%完成全部三项HBV血清学标志物检测,27%为HBV易感者。
- HBsAg阳性者中21%检测HBV DNA、40%检测HBeAg;易感者中50%接种至少1剂乙肝疫苗。
核心结论
- 在大量HCV感染者中,当前或既往HBV感染率较高,但完整乙肝检测、乙肝导向关怀和乙肝疫苗接种均存在缺口。
研究设计与样本
- 回顾性队列分析,使用美国亚特兰大Grady健康系统2004至2016年HCV感染者登记及电子健康记录数据,共4224例。
主要发现
- 4224例中3629例(86%)有HBsAg检测结果,其中43例(1.2%)HBsAg阳性。
- 2342例(55%)完成全部三项HBV血清学标志物检测,中位年龄60岁,67%男性,83%非裔美国人。
- 该2342例中789例(34%)仅anti-HBc阳性,678例(29%)anti-HBc/anti-HBs阳性,190例(8.1%)仅anti-HBs阳性,642例(27%)为HBV易感。
- HBsAg阳性者中21%接受HBV DNA检测,40%接受HBeAg检测。
- HBV易感者中322/642例(50%)接种至少1剂乙肝疫苗。
临床怎么用
- 对HCV感染者应系统评估HBV血清学状态,识别易感者并推动乙肝疫苗接种。
- 对HBsAg阳性者应衔接HBV DNA和HBeAg检测等乙肝导向关怀。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis B virus (HBV) infection testing among persons with hepatitis C virus (HCV) infection is necessary to appropriately care for these patients, yet uptake of HBV testing and vaccination in this population is suboptimal. METHODS: In a retrospective cohort analysis, we describe the prevalence of hepatitis B testing, linkage to hepatitis B care, and hepatitis B vaccination in patients with HCV infection within a large urban safety-net health system. Using a registry of HCV-infected patients with patient-level electronic health record data, that included demographic, clinical, and laboratory information from 2004 to 2016 from Grady Health System in Atlanta, GA, we describe (1) The prevalence of hepatitis B testing (hepatitis B surface antigen [HBsAg], core antibody [anti-HBc], surface antibody [anti-HBs]); (2) The proportion of HBsAg-positive persons receiving HBV DNA and e-antigen (HBeAg) as indicators for linkage to hepatitis B-directed care; and (3) The proportion of persons receiving hepatitis B vaccine. RESULTS: Of 4224 HCV-infected patients, 3629 (86%) had test results for HBsAg and 43 (1.2%) were HBsAg-positive. Of 2342 (55%) with test results for all three HBV serological markers, median age was 60 years, 67% were male, and 83% were African-American, 789 (34%) anti-HBc positive only, 678 (29%) anti-HBc/anti-HBs positive, 190 (8.1%) anti-HBs positive only, and 642 (27%) were HBV-susceptible. Of HBsAg-positive patients, 21% received HBV DNA and 40% HBeAg testing. The proportion of HBV-susceptible patients receiving at least 1 dose of hepatitis B vaccine was 322/642 (50%). CONCLUSIONS: In a large cohort of HCV-infected patients, we found a high prevalence of current or past HBV infection, but there were gaps in complete hepatitis B testing, hepatitis B-directed care, and hepatitis B vaccination. Strategies are needed to increase hepatitis B testing, linkage to care, and administration of the hepatitis B vaccine for HCV-infected persons in this healthcare system.
引用
- Harris AM, Millman AJ, Lora M, et al. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients. Vaccine. 2019. PMID: 30902481. doi:10.1016/j.vaccine.2019.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。